Allen Krantz has had an extensive career in academia and industry. From 1968 to 1980, he was a member of the Faculty of Chemistry at Stony Brook University, holding appointments in both the Department of Chemistry, and the Department of Pharmacological Sciences in the University’s Medical School. From 1981 to 1994, Dr. Krantz was Director, and then. Vice-President of Research at Syntex Research Canada and held Adjunct Professorships during this period at the Universities of Toronto and Guelph while holding the title of Distinguished Scientist at the Corporation… From 1994 to 1997, Dr. Krantz served as Executive Vice President of Research at RedCell, Inc., the forerunner of ConjuChem, (TSX: CJC), and served as the Directeur Scientifique of the European office in France during the same period. Dr. Krantz was responsible for transforming the company’s program to a practical focal point on human serum albumin as a carrier of drugs. He is also a Founder, and served as the inaugural President of Pharmena North America Incorporated, a privately held, biotechnology company. Dr. Krantz obtained his Masters of Science and Ph.D. degrees from Yale University.
